
India’s first COVID-19 vaccine gets clearance for human clinical trials
Web Desk India’s first COVID-19 vaccine COVAXIN has got the Drug Controller General of India’s approval for phase I and II of human clinical trials.
Web Desk India’s first COVID-19 vaccine COVAXIN has got the Drug Controller General of India’s approval for phase I and II of human clinical trials.
Gulf Malayalis
malayali.directory
Copyright ©2025 The Gulf Indians. All Rights Reserved.